ClinicalThought

Share

Program Content

Activities

  • Novel BTKi for CLL/SLL
    Our Experiences and Considerations With Current and Emerging BTK Inhibitors for R/R CLL/SLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 26, 2023

Faculty

cover img faculity

Jennifer R. Brown, MD, PhD

Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Boston, Massachusetts 

cover img faculity

Florence Cymbalista, MD, PhD

Professor of Hematology
Sorbonne Paris Nord University
Bobigny, France

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme, LLC.

Lilly

Merck Sharp & Dohme, LLC